These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21633714)

  • 41. The phenotype of Severe Early Childhood Onset Retinal Dystrophy (SECORD) from mutation of RPE65 and differentiation from Leber congenital amaurosis.
    Weleber RG; Michaelides M; Trzupek KM; Stover NB; Stone EM
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):292-302. PubMed ID: 20811047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retinal pigment epithelium protein of 65 kDA gene-linked retinal degeneration is not modulated by chicken acidic leucine-rich epidermal growth factor-like domain containing brain protein/Neuroglycan C/ chondroitin sulfate proteoglycan 5.
    Cottet S; Jüttner R; Voirol N; Chambon P; Rathjen FG; Schorderet DF; Escher P
    Mol Vis; 2013; 19():2312-20. PubMed ID: 24265546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Membrane-binding and enzymatic properties of RPE65.
    Kiser PD; Palczewski K
    Prog Retin Eye Res; 2010 Sep; 29(5):428-42. PubMed ID: 20304090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RPE65 and retinal dystrophy: Report of new and recurrent mutations.
    Safari S; Zare-Abdollahi D; Bushehri A; Safari MR; Dehghani A; Tahmasebi Z; Khorram Khorshid HR; Ghadami M
    J Gene Med; 2020 Mar; 22(3):e3154. PubMed ID: 31957135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.
    Maguire AM; High KA; Auricchio A; Wright JF; Pierce EA; Testa F; Mingozzi F; Bennicelli JL; Ying GS; Rossi S; Fulton A; Marshall KA; Banfi S; Chung DC; Morgan JI; Hauck B; Zelenaia O; Zhu X; Raffini L; Coppieters F; De Baere E; Shindler KS; Volpe NJ; Surace EM; Acerra C; Lyubarsky A; Redmond TM; Stone E; Sun J; McDonnell JW; Leroy BP; Simonelli F; Bennett J
    Lancet; 2009 Nov; 374(9701):1597-605. PubMed ID: 19854499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65-/- mice.
    Chen Y; Moiseyev G; Takahashi Y; Ma JX
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1177-84. PubMed ID: 16505056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness.
    Van Hooser JP; Aleman TS; He YG; Cideciyan AV; Kuksa V; Pittler SJ; Stone EM; Jacobson SG; Palczewski K
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8623-8. PubMed ID: 10869443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RPE65 is present in human green/red cones and promotes photopigment regeneration in an in vitro cone cell model.
    Tang PH; Buhusi MC; Ma JX; Crouch RK
    J Neurosci; 2011 Dec; 31(50):18618-26. PubMed ID: 22171060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.
    Acland GM; Aguirre GD; Bennett J; Aleman TS; Cideciyan AV; Bennicelli J; Dejneka NS; Pearce-Kelling SE; Maguire AM; Palczewski K; Hauswirth WW; Jacobson SG
    Mol Ther; 2005 Dec; 12(6):1072-82. PubMed ID: 16226919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rpe65 as a modifier gene for inherited retinal degeneration.
    Samardzija M; Wenzel A; Naash M; Remé CE; Grimm C
    Eur J Neurosci; 2006 Feb; 23(4):1028-34. PubMed ID: 16519667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PlGF gene knockdown in human retinal pigment epithelial cells.
    Akrami H; Soheili ZS; Sadeghizadeh M; Ahmadieh H; Rezaeikanavi M; Samiei S; Khalooghi K
    Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):537-46. PubMed ID: 21104270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium.
    Jin M; Li S; Moghrabi WN; Sun H; Travis GH
    Cell; 2005 Aug; 122(3):449-59. PubMed ID: 16096063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.
    Hauswirth WW; Aleman TS; Kaushal S; Cideciyan AV; Schwartz SB; Wang L; Conlon TJ; Boye SL; Flotte TR; Byrne BJ; Jacobson SG
    Hum Gene Ther; 2008 Oct; 19(10):979-90. PubMed ID: 18774912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early apoptosis of rod photoreceptors in Rpe65(-/-) mice is associated with the upregulated expression of lysosomal-mediated autophagic genes.
    Métrailler S; Schorderet DF; Cottet S
    Exp Eye Res; 2012 Mar; 96(1):70-81. PubMed ID: 22227450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impairment of the transient pupillary light reflex in Rpe65(-/-) mice and humans with leber congenital amaurosis.
    Aleman TS; Jacobson SG; Chico JD; Scott ML; Cheung AY; Windsor EA; Furushima M; Redmond TM; Bennett J; Palczewski K; Cideciyan AV
    Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1259-71. PubMed ID: 15037595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of gene transfer for Leber's congenital amaurosis.
    Maguire AM; Simonelli F; Pierce EA; Pugh EN; Mingozzi F; Bennicelli J; Banfi S; Marshall KA; Testa F; Surace EM; Rossi S; Lyubarsky A; Arruda VR; Konkle B; Stone E; Sun J; Jacobs J; Dell'Osso L; Hertle R; Ma JX; Redmond TM; Zhu X; Hauck B; Zelenaia O; Shindler KS; Maguire MG; Wright JF; Volpe NJ; McDonnell JW; Auricchio A; High KA; Bennett J
    N Engl J Med; 2008 May; 358(21):2240-8. PubMed ID: 18441370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retinal gene expression and visually evoked behavior in diabetic long evans rats.
    Kirwin SJ; Kanaly ST; Hansen CR; Cairns BJ; Ren M; Edelman JL
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7654-63. PubMed ID: 21862641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.
    Simonelli F; Maguire AM; Testa F; Pierce EA; Mingozzi F; Bennicelli JL; Rossi S; Marshall K; Banfi S; Surace EM; Sun J; Redmond TM; Zhu X; Shindler KS; Ying GS; Ziviello C; Acerra C; Wright JF; McDonnell JW; High KA; Bennett J; Auricchio A
    Mol Ther; 2010 Mar; 18(3):643-50. PubMed ID: 19953081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prenatal human ocular degeneration occurs in Leber's congenital amaurosis (LCA2).
    Porto FB; Perrault I; Hicks D; Rozet JM; Hanoteau N; Hanein S; Kaplan J; Sahel JA
    J Gene Med; 2002; 4(4):390-6. PubMed ID: 12124981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nrl-knockout mice deficient in Rpe65 fail to synthesize 11-cis retinal and cone outer segments.
    Feathers KL; Lyubarsky AL; Khan NW; Teofilo K; Swaroop A; Williams DS; Pugh EN; Thompson DA
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1126-35. PubMed ID: 18326740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.